SPACInsider Logo
New Addition to the Yield-To-Maturity Tables…
by Kristi Marvin on 2018-12-13 at 1:05pm

Some of you may have already noticed, but yesterday, we added two new tables to the Yield-To-Maturity page.  However, a bit of background first….

The initial Yield-To-Maturity tables we published used a very conservative method whereby we used either the trust value at IPO (for SPACs still searching for targets) or the “illustrative value” that SPACs use in their proxies or presentations (for announced SPACs) to calculate the YTM.  This is the safest way to calculate a YTM figure, but it never reflects the actual cash per share value at this current moment in time.  This is particularly true for “announced SPACs” that use an illustrative value based on their most recent 10-Q, so the value is almost always a couple of months out of date.

While this is the conservative, and arguably the safest way to approach the YTM calculation, it always felt…kind of lame. Hence, we decided to publish a second set of tables based on our own estimates.  Our models take into account the taxes (income and franchise, if any – BVI, Cayman), interest rates, any withdrawls from interest income for working capital purposes and contributions to trust for extensions to arrive at the current trust balance and ultimately, the implied cash per share value. To make our estimated cash per share values easy to find, we’ve highlighted those columns in yellow.

However, a few notes:  There are a few SPACs that have an illustrative value that projects what they are estimating to be the cash per share value at vote.  MTech does this.  MTech does not expect to close their transaction until Q1 of 2019, but they have already estimated that their pro rata cash amount will be $10.16 at the time of the vote.  Hence, you will see MTech’s value of $10.16 under the “Announced: Illustrative Values” table, but only $10.14 under the “Announced:  Estimated Values” table, since the Estimated tables are reflecting what’s currently in trust RIGHT NOW, not in Q-1 2019.  Additionally, we believe we have a very accurate model, but it’s still just an estimate. Please keep that in mind.

Finally, we may be tweaking the layout in the coming weeks to make the tables easier to read and we will also be re-working the current Redemption Prices page to better reflect these changes.  Plus, we intend to also publish our estimated trust balances on the forthcoming “new” Redemption Prices page as well.

We hope you find the new tables useful and we look forward to continuing to improve and provide meaningful data to our subscribers.

Recent Posts
by Marlena Haddad on 2022-12-01 at 11:25am

  Below is a daily summary of links to the latest SPAC news and rumors gathered across the web.  Latest SPAC News:  NYSE president says IPO proceeds fall more than 90% while Nasdaq president remains hopeful for 2023, and Giuliani brothers sell pharma stocks as they invest in biotech SPACs NYSE president says IPO proceeds fall...

by Marlena Haddad on 2022-12-01 at 10:02am

InterPrivate II Acquisition Corp. (NYSE:IPVA) disclosed this morning that it has restructured its bonus share agreement in connection to its proposed merger with carsharing marketplace Getaround. The parties previously agreed to reserve and set aside the bonus shares, consisting of 9,333,333 shares, to be allocated to the non-redeeming public stockholders, the designees of EarlyBirdCapital and the...

by Nicholas Alan Clayton on 2022-12-01 at 9:31am

Iris Acquisition Corp. (NASDAQ:IRAA) has entered into a definitive agreement to combine with biotech firm Liminatus at an enterprise value of $334 million. La Palma, California-based Liminatus is a clinical-stage drug developer working on a range of cancer treatments utilizing both preventative vaccines and CAR-T therapies. The combined company is expected to trade on the...

by Marlena Haddad on 2022-12-01 at 9:22am

Lakeshore Acquisition Corp. I (NASDAQ:LAAA) announced this morning that it has entered into a non-redemption agreement and amended its purchaser support agreement with initial shareholders in connection to its proposed merger with medical device company ProSomnus. The SPAC entered into non-redemption agreements with certain institutional investors for an aggregate of 200,339 shares of the purchaser. These investors...

by Nicholas Alan Clayton on 2022-11-30 at 6:01pm

The companies and sponsors of six SPAC deals are set to see their lock-ups expire before the end of the year. This is a relatively small monthly total as the wave of deals from 2020 and 2021 are still hitting this milestone. The list nonetheless includes some major names starting with Forafric (NASDAQ:AFRI), which is...

Privacy Policy|Terms Of Use
Copyright © 2022 SPACInsider, Inc. All Rights Reserved